Rowland & Co. Investment Counsel ADV decreased its stake in shares of ConocoPhillips (NYSE:COP – Free Report) by 4.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 42,853 shares of the energy producer’s stock after selling 1,844 shares during the […]
Rowland & Co. Investment Counsel ADV trimmed its holdings in shares of FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 9.4% in the second quarter, according to its most recent filing with the SEC. The firm owned 770 shares of the business services provider’s stock after selling 80 shares during the period. Rowland & […]
Rowland & Co. Investment Counsel ADV bought a new stake in shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 1,830 shares of the company’s stock, valued at approximately $103,000. Several other hedge […]
Rowland & Co. Investment Counsel ADV lowered its position in The Progressive Co. (NYSE:PGR – Free Report) by 1.3% during the 2nd quarter, Holdings Channel reports. The fund owned 129,898 shares of the insurance provider’s stock after selling 1,681 shares during the period. Progressive makes up 4.1% of Rowland & Co. Investment Counsel ADV’s portfolio, […]
Rowland & Co. Investment Counsel ADV lowered its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,135 shares of the biotechnology company’s stock after selling 1,010 shares during the […]